The Impact of Inflammation Control and Active Cancer Palliation on Metabolic Pathways Determining Tumor Progression and Patient Survival

作者: Ulrika Smedh , Annika Gustafsson , Hans Axelsson , Christian Cahlin , Christina Lönnroth

DOI: 10.1007/978-90-481-9531-2_15

关键词:

摘要: Strong associations are assumed between inflammation, cancer initiation, and tumor progression. Weight loss cachexia predispose for early death in disease. Usually, such conditions characterized by systemic which is easily monitored increased blood levels of C-reactive protein an elevated erythrocyte sedimentation rate. Hypothetically, eicosanoids or, more specifically, prostaglandins could be common mediators the promotion fatigue syndrome. Consequently, prostaglandins, particularly prostaglandin E2, have been reported to involve development anorexia, altered resting energy expenditure, neoangiogenesis, whole-body fat cell metabolism, as well circulatory homeostasis progressive

参考文章(225)
Everett E. Vokes, Mark J. Green, Martin J. Edelman, Dee Watson, Xiaofei Wang, Carl Morrison, Robert A. Kratzke, Scott Jewell, Lydia Hodgson, Ann M. Mauer, Ajeet Gajra, Gregory A. Masters, Michelle Bedor, Eicosanoid Modulation in Advanced Lung Cancer: Cyclooxygenase-2 Expression Is a Positive Predictive Factor for Celecoxib + Chemotherapy--Cancer and Leukemia Group B Trial 30203 Journal of Clinical Oncology. ,vol. 26, pp. 848- 855 ,(2008) , 10.1200/JCO.2007.13.8081
Nicola M. Neary, Caroline J. Small, Alison M. Wren, Jennifer L. Lee, Maralyn R. Druce, Carlo Palmieri, Gary S. Frost, Mohammad A. Ghatei, R. Charles Coombes, Stephen R. Bloom, Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo-controlled trial. The Journal of Clinical Endocrinology and Metabolism. ,vol. 89, pp. 2832- 2836 ,(2004) , 10.1210/JC.2003-031768
Pasha Sarraf, Elisabetta Mueller, Wendy M Smith, Harold M Wright, Jennifer B Kum, Lauri A Aaltonen, Albert de la Chapelle, Bruce M Spiegelman, Charis Eng, Loss-of-Function Mutations in PPARγ Associated with Human Colon Cancer Molecular Cell. ,vol. 3, pp. 799- 804 ,(1999) , 10.1016/S1097-2765(01)80012-5
Michael J. Bevan, Helping the CD8+ T-cell response Nature Reviews Immunology. ,vol. 4, pp. 595- 602 ,(2004) , 10.1038/NRI1413
N Kanai, R Lu, J. Satriano, Y Bao, A. Wolkoff, V. Schuster, Identification and characterization of a prostaglandin transporter Science. ,vol. 268, pp. 866- 869 ,(1995) , 10.1126/SCIENCE.7754369
K Hiraoka, M Miyamoto, Y Cho, M Suzuoki, T Oshikiri, Y Nakakubo, T Itoh, T Ohbuchi, S Kondo, H Katoh, Concurrent infiltration by CD8+ T cells and CD4+ T cells is a favourable prognostic factor in non-small-cell lung carcinoma British Journal of Cancer. ,vol. 94, pp. 275- 280 ,(2006) , 10.1038/SJ.BJC.6602934
Valeriy Sergeyev, Christian Broberger, Tomas Hökfelt, Effect of LPS administration on the expression of POMC, NPY, galanin, CART and MCH mRNAs in the rat hypothalamus Molecular Brain Research. ,vol. 90, pp. 93- 100 ,(2001) , 10.1016/S0169-328X(01)00088-2
Leahy, Mulcahy, O'Donoghue, Parfrey, bcl-2 protein expression is associated with better prognosis in colorectal cancer. Histopathology. ,vol. 35, pp. 360- 367 ,(1999) , 10.1046/J.1365-2559.1999.00743.X
Yukihiro Funada, Tsuyoshi Noguchi, Ryuichi Kikuchi, Shinsuke Takeno, Yuzo Uchida, Helmut Gabbert, Prognostic significance of CD8+ T cell and macrophage peritumoral infiltration in colorectal cancer. Oncology Reports. ,vol. 10, pp. 309- 313 ,(2003) , 10.3892/OR.10.2.309
Sarah G Harris, Josue Padilla, Laura Koumas, Denise Ray, Richard P Phipps, Prostaglandins as modulators of immunity Trends in Immunology. ,vol. 23, pp. 144- 150 ,(2002) , 10.1016/S1471-4906(01)02154-8